Eterna Therapeutics News

Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science

CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- Factor Bioscience Inc. ("Factor"), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, t

PR NewswireApr 9 07:30 ET

Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More

Seeking AlphaMar 24 08:01 ET

Express News | Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Moomoo 24/7Mar 22 16:37 ET

Press Release: Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to Its Board of Directors

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or t

Dow JonesFeb 20 08:30 ET

Eterna Therapeutics Welcomes New Board Member Peter Cicala

TipRanksFeb 16 07:42 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersRevance Therapeutics (NASDAQ:RVNC) shares moved upwards by 16.5% to $6.0 during Friday's pre-market session. The company's market cap stands at $526.8 million. Eterna Therapeutics (NASDAQ:ERNA)

BenzingaFeb 2 08:06 ET

Eterna Therapeutics Files to Sell 18.2M Shares for Holders

Seeking AlphaJan 12 16:56 ET

Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (C)(4)

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering to provide

GlobeNewswireJan 3 16:15 ET

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

Yahoo FinanceDec 21, 2023 11:18 ET

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering to provide

GlobeNewswireDec 20, 2023 16:15 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersAclarion (NASDAQ:ACON) shares rose 75.8% to $0.51 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.8 million. Longeveron (NASDAQ:LGVN) stock rose 43.

BenzingaDec 20, 2023 08:07 ET

Eterna Therapeutics Launches Convertible Debt and Warrant Financing of up to $9.2M

Seeking AlphaDec 15, 2023 12:37 ET

Eterna Therapeutics Announces $9.2M Convertible Debt And Warrant Financing

Eterna Therapeutics Inc. a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the execution of

BenzingaDec 15, 2023 02:00 ET

Press Release: Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing CAMBRIDGE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or the "Compan

Dow JonesDec 14, 2023 18:56 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersC4 Therapeutics (NASDAQ:CCCC) stock increased by 100.5% to $2.37 during Tuesday's regular session. The market value of their outstanding shares is at $116.6 million. Aditxt (NASDAQ:ADTX) shares

BenzingaDec 12, 2023 12:31 ET

PAVM, CCLD and EDSA Among Mid-day Movers

Seeking AlphaDec 12, 2023 12:30 ET

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersReshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 17.9% to $0.31 during Wednesday's after-market session. The market value of their outstanding shares is at $4.0 million. Monopar Therap

BenzingaDec 6, 2023 16:31 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersLucy Scientific Discovery (NASDAQ:LSDI) shares increased by 46.4% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.2 million. Lexeo Therapeuti

BenzingaDec 1, 2023 16:31 ET

Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors

Yahoo FinanceNov 2, 2023 11:48 ET

Press Release: Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics In

Dow JonesNov 1, 2023 08:30 ET